BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12614325)

  • 1. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
    Gross CE; Ravenscroft P; Dovero S; Jaber M; Bioulac B; Bezard E
    J Neurochem; 2003 Mar; 84(6):1246-55. PubMed ID: 12614325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK; Samadi P; Morissette M; Grégoire L; Ouattara B; Lévesque D; Rouillard C; Di Paolo T
    Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M; Grondin R; Goulet M; Bédard PJ; Di Paolo T
    J Neurochem; 1999 Feb; 72(2):682-92. PubMed ID: 9930741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
    Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.
    Tel BC; Zeng BY; Cannizzaro C; Pearce RK; Rose S; Jenner P
    Neuroscience; 2002; 115(4):1047-58. PubMed ID: 12453478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
    Bordet R; Ridray S; Schwartz JC; Sokoloff P
    Eur J Neurosci; 2000 Jun; 12(6):2117-23. PubMed ID: 10886351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.
    Henry B; Duty S; Fox SH; Crossman AR; Brotchie JM
    Exp Neurol; 2003 Oct; 183(2):458-68. PubMed ID: 14552886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei.
    Meissner W; Dovero S; Bioulac B; Gross CE; Bezard E
    Neurobiol Dis; 2003 Jun; 13(1):46-54. PubMed ID: 12758066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
    Guigoni C; Dovero S; Aubert I; Li Q; Bioulac BH; Bloch B; Gurevich EV; Gross CE; Bezard E
    Eur J Neurosci; 2005 Jul; 22(1):283-7. PubMed ID: 16029219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
    Ravenscroft P; Chalon S; Brotchie JM; Crossman AR
    Exp Neurol; 2004 Jan; 185(1):36-46. PubMed ID: 14697317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey.
    Quik M; Police S; Langston JW; Di Monte DA
    Neuroscience; 2002; 113(1):213-20. PubMed ID: 12123699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment.
    Quik M; Police S; He L; Di Monte DA; Langston JW
    Neuroscience; 2000; 98(2):263-73. PubMed ID: 10854757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
    Périer C; Marin C; Jimenez A; Bonastre M; Tolosa E; Hirsch EC
    J Neurochem; 2003 Sep; 86(6):1328-37. PubMed ID: 12950442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.
    Aubert I; Guigoni C; Håkansson K; Li Q; Dovero S; Barthe N; Bioulac BH; Gross CE; Fisone G; Bloch B; Bezard E
    Ann Neurol; 2005 Jan; 57(1):17-26. PubMed ID: 15514976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata.
    Wang H; Katz J; Dagostino P; Soghomonian JJ
    Neuroscience; 2007 Mar; 145(2):727-37. PubMed ID: 17218060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.
    Périer C; Marin C; Bonastre M; Tolosa E; Hirsch EC
    Eur J Neurosci; 2002 Dec; 16(11):2236-40. PubMed ID: 12473092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
    Ishiwata K; Koyanagi Y; Abe K; Kawamura K; Taguchi K; Saitoh T; Toda J; Senda M; Sano T
    J Neurochem; 2001 Nov; 79(4):868-76. PubMed ID: 11723179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.